Hospitals participating in certain voluntary valued-based reforms have reduced their readmissions more than hospitals participating in only the mandatory Hospital Readmissions Reduction Program, according to a study reported today in JAMA Internal Medicine. Based on readmissions data for 2,837 hospitals between 2008 and 2015, the study found that hospitals achieving meaningful use under the Medicare and Medicaid Electronic Health Records Incentive Programs or participating in Medicare’s accountable care organizations or Bundled Payment for Care Initiative achieved greater reductions in readmissions under the HRRP. Participation in more than one of the three voluntary programs led to additional improvement. Hospitals participating in all three voluntary programs reduced their readmissions by an additional 1.27 percentage points for heart attack, 1.64 percentage points for heart failure and 1.05 percentage points for pneumonia. The authors estimate that hospital participation in the three voluntary programs in 2015 led to 2,377 fewer readmissions, saving Medicare more than $32.7 million.
The Centers for Medicare & Medicaid Services has extended the deadline for submitting third-quarter data to the Post-Acute Care Quality Reporting Program.
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Hospitals and clinicians are seeing fewer flu patients this season than in other recent years, the Centers for Disease Control and Prevention reports.
Insights and Analysis
Share how your organization is working to improve health equity – apply for the AHA Equity of Care Award Applications for the 2019 AHA Equity of Care Award are due by Feb. 19
Please consider applying for the award and sharing how your organization is improving health equity and value.
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…